Abstract
AVIAN sarcoma virus 17 induces fibrosarcomas in chickens1 and can transform a number of avian cell types in vitro2 by the action of v-jun (refs 1–3). This gene and the related cellular genes c-jun4–6, jun B7 and jun D8,9, encode transactivating (or repressing) DNA-binding proteins that form homo- or heterodimeric (Jun–Jun and Jun–Fos) complexes5,10,11 which recognize the AP-1 consensus sequence TGACTCA (refs 12,13), a response element that confers sensitivity to the tumour-promoting phorbol ester TPA14. We have produced several lines of transgenic mice carrying the v-jun oncogene, driven by the promoter of the widely expressed H-2Kk major histocompatibility complex (MHC) class I antigen gene. Transgenic animals are initially phenotypically normal, but after full-thickness wounding they show abnormal wound repair, characterized by hyperplastic granulation tissue. Many of these lesions are slowly progressive because of continuing fibrob blast proliferation, and over 2–5 months some give rise to dermal fibrosarcomas. This reproducible multistep transition through a proliferative but benign intermediate is associated with characteristic increments in v-jun expression. Moreover, hyperplastic wound repair and its progression are both related to transgene dosage, suggesting that there exists a quantitative requirement or threshold for v-jun action. Our results indicate that v-jun is not oncogenic in transgenic mice as a result of a 'single-hit' mechanism, but rather, in addition to an obligatory wound, that secondary genetic or epigenetic events (possibly conscripting normal constituents of wound repair) are necessary for tumour development and progression.
Similar content being viewed by others
References
Maki, Y., Bos, T. J., Davis, C., Starbuck, M. & Vogt, P. K. Proc. natn. Acad. Sci. U.S.A. 84, 2848–2852 (1987).
Vogt, P. K. & Tjian, R. Oncogene 3, 3–7 (1988).
Bos, T. J., Bohmann, D., Tsuchie, H., Tjian, R. & Vogt, P. K. Cell 52, 705–712 (1988).
Bohmann, D. et al. Science 238, 1386–1392 (1987).
Rauscher F. J. III, et al. Science 240, 1010–1016 (1988).
Angel, P. et al. Nature 332, 166–171 (1988).
Ryder, K., Lau, L. F. & Nathans, D. Proc. natn. Acad. Sci. U.S.A. 85, 1487–1491 (1988).
Ryder, K., Lanahan, A., Perez-Albuerne, E. & Nathans, D. Proc. natn. Acad. Sci. U.S.A. 86, 1500–1503 (1989).
Hirai, S.-I., Ryseck, R.-P., Mechta, F., Bravo, R. & Yaniv, M. EMBO J. 8. 1433–1439 (1989).
Chiu, R. et al. Cell 54, 541–552 (1988).
Halazonetis, T. D., Georgopoulos, K., Greenberg, M. E. & Leder, P. Cell 55, 917–924 (1988).
Lee, W., Haslinger, A., Karin, M. & Tjian, R. Nature 325, 368–372 (1987).
Lee, W., Mitchell, P. & Tjian, R. Cell 49, 741–752 (1987).
Angel, P. et al. Cell 49, 729–739 (1987).
Arnold, B., Burgert, H.-G., Archibald, A. L. & Kvist, S. Nucleic Acids Res. 12, 9473–9487 (1984).
Clark, R. A. F. in The Molecular and Cellular Biology of Wound Repair (eds Clark, R. A. F. & Henson, P. M.) 3–33 (Plenum, New York, 1988).
Sporn, M. B. & Roberts, A. B. J. clin. Invest. 78, 329–332 (1986).
Brenner, M. K. Br. J. Haemat. 69, 149–152 (1988).
Steenfos, H. H., Hunt, T. K., Scheuenstuhl, H. & Goodson, W. H. Surgery 106, 171–176 (1989).
Dinarello, C. A. FASEB J. 2, 108–115 (1988).
Rappolee, D. A., Mark, D., Banda, M. J. & Werb, Z. Science 241, 708–712 (1988).
Israel, A., Kimura, A., Fournier, A., Fellous, M. & Kourilsky, P. Nature 322, 743–746 (1986).
Israel, A. et al. EMBO J. 8, 3793–3800 (1989).
Muegge, K. et al. Science 246, 249–251 (1989).
Haddow, A. Adv. Cancer Res. 16, 181–234 (1972).
Van Den Hooff, A. Adv. Cancer Res. 50, 159–195 (1988).
Dolberg, D. S., Hollingsworth, R., Hertle, M. & Bissell, M. J. Science 230, 676–678 (1985).
Argyris, T. S. CRC Crit. Rev. Toxicol. 14, 211–258 (1984).
Lacey, M., Alpert, S. & Hanahan, D. Nature 322, 609–612 (1986).
Hanahan, D., Alpert, S., & Lacey, M. in Viral Carcinogenesis (eds Kjeldgaard, N.O. & Forchhammer, J.) 263–274 (Munksgaard, Copenhagen, 1987).
Sippola-Thiele, M., Hanahan, D. & Howley, P. M. Molec. cell. Biol. 9, 925–934 (1989).
Breitman, M. L. et al. Science 238, 1563–1565 (1987).
Hogan, B., Constantini, F. & Lacy, E. (eds). Manipulating the Mouse Embryo: A Laboratory Manual (Cold Spring Harbor Laboratory, 1986).
Curran, T., Gordon, M. B., Rubino, K. L. & Sambucetti, L. C. Oncogene 2, 79–84 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schuh, A., Keating, S., Monteclaro, F. et al. Obligatory wounding requirement for tumorigenesis in v-jun transgenic mice. Nature 346, 756–760 (1990). https://doi.org/10.1038/346756a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/346756a0
- Springer Nature Limited
This article is cited by
-
The biology and function of fibroblasts in cancer
Nature Reviews Cancer (2016)
-
T-cell activation promotes tumorigenesis in inflammation-associated cancer
Retrovirology (2009)
-
Cancer as an overhealing wound: an old hypothesis revisited
Nature Reviews Molecular Cell Biology (2008)
-
Extracellular matrix control of mammary gland morphogenesis and tumorigenesis: insights from imaging
Histochemistry and Cell Biology (2008)
-
Mouse Models of Psoriasis
Journal of Investigative Dermatology (2007)